Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.
作者信息
Cantrell J E, Brunet R, Lagarde C, Schein P S, Smith F P
出版信息
Cancer Treat Rep. 1982 Jul;66(7):1563-5.
PMID:7093972
Abstract
Eighteen patients with previously untreated advanced colorectal cancer were treated with a sequential methotrexate-5-FU regimen. One of 16 evaluable patients achieved a partial response. The results of this and other clinical and laboratory investigations reported to date suggest that further study of different doses and schedules of sequential methotrexate-5-FU is warranted.
摘要
Zotero 插件